Manufacturer of generic drugs of Sotolaxib (AMG510)

Sotoracib (AMG510) is a small molecule targeted inhibitor mainly used to treat KRAS G12C mutant locally advanced or metastatic non-small cell lung cancer. With the recognition of its efficacy, some pharmaceutical companies have begun to try to produce generic drugs. At present, in addition to the original research manufacturer Amgen of the United States, Lucius of Laos, Daxiong Pharmaceutical, Everest Pharmaceutical of Bangladesh, etc. are also manufacturers of generic drugs of sotolasibu. These generic drug manufacturers need to strictly follow relevant production standards and regulatory requirements during the production process to ensure that the quality, safety and efficacy of the generic drugs are as close as possible to the original drugs.